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Obesity during pregnancy increases the risk for maternal complications like gestational dia-
betes, preeclampsia, and maternal inflammation. Maternal obesity also increases the risk of
childhood obesity, intrauterine growth restriction (IUGR) and diabetes to the offspring.
Increased circulating free fatty acids (FFAs) in obesity due to adipose tissue lipolysis
induces lipoapoptosis to hepatocytes, cholangiocytes, and pancreatic-β-cells. During the
third trimester of human pregnancy, there is an increase in maternal lipolysis and release of
FFAs into the circulation. It is currently unknown if increased FFAs during gestation as a
result of maternal obesity cause placental cell lipoapoptosis. Increased exposure of FFAs
during maternal obesity has been shown to result in placental lipotoxicity. The objective of
the present study is to determine saturated FFA-induced trophoblast lipoapoptosis and also
to test the protective role of monounsaturated fatty acids against FFA-induced trophoblast
lipoapoptosis using in vitro cell culture model. Here, we hypothesize that saturated FFAs
induce placental trophoblast lipoapoptosis, which was prevented by monounsaturated fatty
acids.
Methods
Biochemical and structural markers of apoptosis by characteristic nuclear morphological
changes with DAPI staining, and caspase 3/7 activity was assessed. Cleaved PARP and
cleaved caspase 3 were examined by western blot analysis.
Results
Treatment of trophoblast cell lines, JEG-3 and JAR cells with palmitate (PA) or stearate
(SA) induces trophoblast lipoapoptosis as evidenced by a significant increase in apoptotic
nuclear morphological changes and caspase 3/7 activity. We observed that saturated FFAs
caused a concentration-dependent increase in placental trophoblast lipoapoptosis. We also
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observed that monounsaturated fatty acids like palmitoleate and oleate mitigates placental
trophoblast lipoapoptosis caused due to PA exposure.
Conclusion
We show that saturated FFAs induce trophoblast lipoapoptosis. Co-treatment of monoun-
saturated fatty acids like palmitoleate and oleate protects against FFA-induced trophoblast
lipoapoptosis.
Introduction
The prevalence of obesity is an epidemic in the United States as approximately 67% of US pop-
ulation is either obese or overweight [1, 2]. Sixty percent of all pregnant women in the US are
predicted to be either overweight or obese [3–6]. Obese women have reproductive disorders
complicating pregnancy and perinatal outcomes including ovulation defects, infertility, gesta-
tional diabetes, early pregnancy loss and birth defects [7, 8]. Pre-gravid obesity or excessive
gestational weight gain has been shown to increase the risk of preeclampsia, intrauterine
growth restriction (IUGR), preterm birth, stillbirth, and macrosomia [9]. Maternal obesity
also increases the risk for metabolic diseases to the offspring latter in their life [4, 10–12].
Obesity or metabolic syndrome increases adipose tissue lipolysis during the overnight fast-
ing time and leads to an increased level of FFA in the circulation [13]. Maternal adipose tissue
lipolysis is enhanced in the third trimester of pregnancy and increases the flux of FFA to the
fetus via the placenta, which is even greater in obese mothers [14, 15]. Recent clinical study
showed that obese mothers were observed to have increased accumulation of placental lipids
compared non-obese mother [16], contributing to the placental lipotoxicity and cellular stress
[6, 17–19]. Palmitate is the predominant saturated fatty acid in diets and are elevated in the cir-
culation of obese women compared to lean control [20]. Further, placental trophoblast apopto-
sis were also reported in obese mothers [21]. It was suggested that monounsaturated fatty
acids could have a protective role against placental lipotoxicity [20, 22, 23]. However, an
important gap in knowledge exists on the causal role of FFA-induced placental lipotoxicity
and the protective role of mono-unsaturated fatty acids. Further, a decreased palmitate catabo-
lism and an increased lipid droplets accumulation were observed in term placental trophoblast
obtained from obese mother compared to lean mother [2]. The objective of this study is to
determine saturated FFA-induced trophoblast lipoapoptosis and also to test the protective role
of monounsaturated fatty acids against FFA-induced trophoblast lipoapoptosis using in vitro
cell culture model. In the present study, we hypothesized that exposure of saturated FFAs to
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Antibodies
Rabbit antisera against PARP (9542S), cleaved caspase 3 (#9664) were from Cell Signaling,
Danvers, Massachusetts, USA. Actin antibody (#A-5441) was from MilliporeSigma, St. Louis,
Missouri, USA. Peroxidase-conjugated secondary antibodies were obtained from Jackson
ImmunoResearch lab, West Grove, Pennsylvania, USA.
Cell lines and treatment
HTR-8SV/neo (HTR-8), normal human immortalized first-trimester placental trophoblast
cells, and choriocarcinoma-derived third-trimester placental trophoblast cell lines (JEG-3 and
JAR) were used. JEG-3 and JAR cells has similar biochemical and biological characteristics of
human term-derived trophoblasts. JAR and HTR-8 cells were cultured in DMEM containing
10% fetal bovine serum, 0.01% plasmocin and JEG-3 cells were cultured in MEM containing
10% fetal bovine serum, and 0.01% plasmocin as described [24]. All the cells used in the pres-
ent study were obtained from the American type culture collection (ATCC) and periodically
tested for mycoplasma.
Fatty acid preparation
Fatty acids, palmitic acid (PA), stearic acid (SA), Oleic acid (OA) and palmitoleic acid (PO)
were dissolved in isopropanol with a stock solution of 80 mM. These fatty acids were incubated
with growth media containing 1% BSA for 20 minutes at 37˚C for fatty acid-BSA conjugation
and then treated for 24 hours. BSA (1%) was dissolved in growth media at room temperature
and incubated at 37˚C for 30 minutes prior to the addition of fatty acids. We have used various
concentrations of FFAs (200–800 μM) in the present study and vehicle (Veh) treatment were
<1% isopropanol in 1% BSA containing medium. The concentration range of FFAs used in
the present study mimics physiological to pathophysiological concentrations.
Measurement of apoptosis
Structural and biochemical markers of apoptosis like percent apoptotic nulcei and caspase 3/7
activity, respectively were assessed. Percent apoptotic nuclei was quantified by characteristic
nuclear morphological changes and visualized by treatment with the fluorescent DNA-binding
dye, DAPI (4’, 6-diamidine-2-phenylindole dihydrochloride) as described [25]. Briefly, cells
were stained with 5 μg/ml of DAPI for 20–30 minutes at 37˚C. Apoptotic nuclei (condensed,
fragmented) were counted and presented as a percent of total nuclei. At least 200 cells were
counted per well and experiments were performed in triplicate. Caspase 3/7 activity was mea-
sured using rhodamine 110 bis-(N-CBZ-I-aspartyl-I-glutamyl-I-Valyl-aspartic acid amide
(Z-DEVD-R110) substrate. The caspase 3 and 7 enzyme activity in the cells will cleave the
DEVD peptide in the substrate and release the rhodamine 110 fluorophore which can be mea-
sured spectrofluorometrically (Biotek Synergy) with 498nm wavelength of excitation and
521nm emission. The activity is measured by net fluorescence (assay rate of fluorescence
(RFU)—negative control RFU) according to the manufacturer’s instructions (APO-One, Pro-
mega, Madison, WI #G7791). The data were reported as fold-change of net fluorescence com-
pared to vehicle treated cells, with experiments performed in quadruplicate.
Immunoblot analysis
Cells were rinsed once with ice-cold phosphate buffered saline (PBS) and cell lysates were pre-
pared by scraping the cells in lysis buffer containing 50 mM tris, 150 mM sodium chloride, 1
mM ethylene diamine tetra acetic acid, 1 mM dithiothreitol, 1 mM α-phenyl methyl sulfonyl
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fluoride, 1 mM sodium orthovanadate, 100 mM sodium fluoride, and 1% triton X-100 along
with the addition of mammalian protease inhibitor cocktail (Roche). After 40 minutes incuba-
tion on ice, whole cell lysates were centrifuged at 15,000 x g for 10 min to remove insoluble
proteins. Cell lysates containing 25–30 μg of protein were resolved by SDS-PAGE. Proteins
were transferred to a nitrocellulose membrane and visualized by immunoblotting. Briefly,
transferred membrane were blocked in 5% milk powder dissolved in PBST (0.1% Tween 20 in
PBS) and incubated overnight in primary antibodies with a dilution of 1 in 1000 at 4˚C. After
three washes for 10 minutes in PBST at room temperature, respective peroxidase-conjugated
secondary antibodies were incubated for 90 minutes. The band intensity was developed using
Chemidoc, Bio-Rad, Hercules, California, USA.
Statistics
Data are expressed as mean ± standard error of mean (SEM). Statistical analysis of apoptotic
nuclei levels and caspase 3/7 activity for each fatty acid was performed using one-way analysis
of variance (ANOVA) with fatty acid concentration as the fixed effect and a Bonferroni post-
hoc correction. A Bonferroni adjusted P value < 0.05 was accepted as statistically significant.
Statistical calculations were performed using SPSS Statistics for Windows, Version 26.0.
Armonk, New York: IBM Corp., USA.
Results
Saturated FFAs induce trophoblast lipoapoptosis
We assessed biochemical characteristics of apoptosis like nuclear morphological changes and
caspase 3/7 activity. Treatment of placental trophoblast cells, JEG-3 with saturated FFAs such
as palmitate and stearate for 24 h showed trophoblast lipoapoptosis. We observed a significant
increase in percent apoptotic nuclei levels and caspase 3/7 activity with increasing the concen-
tration of palmitate or stearate (400–800 μM) treatment compared to vehicle treated cells (Fig
1A and 1B). In addition, treatment of 200 μM palmitate for 24 h in JEG-3 cells showed a sig-
nificant increase in caspase 3/7 activity compared to vehicle treated cells, however the percent
apoptotic nuclei levels were not increased with 200 μM palmitate compared to vehicle treated
cells (Fig 1A and 1B). Treatment of oleate (200–600 μM, 24 h) to JEG-3 cells did not induce
trophoblast lipoapoptosis (Fig 1A and 1B). However, oleate treatment did show slight but sig-
nificant increase in percent apoptotic nuclear morphological changes indicating cell death
only at 800 μM of oleate, highest concentration of oleate tested (Fig 1A). We also observed
increased percent apoptotic nuclei and caspase 3/7 activity with 600–800 μM of palmitate for
24 h in JAR cells, another choriocarcinoma-derived trophoblast (Fig 1C and 1D). Similarly,
treatment of stearate (400–800 μM) for 24 hours also showed a significant increase in percent
apoptotic nuclear morphological changes and caspase 3/7 activation in JAR cells compared to
vehicle treated cells (Fig 1C and 1D). In JAR cells, treatment of monounsaturated fatty acid,
oleate (200–800μM, 24 h) did not alter the levels of percent apoptotic nuclei and caspase 3 and
7 activity compared to vehicle treated cells (Fig 1C and 1D). These data suggest that saturated
FFAs induce trophoblast lipoapoptosis.
We further used HTR-8 cells and observed that palmitate and stearate treatment for 24 h
showed a concentration dependent increase in trophoblast lipoapoptosis as evidenced by an
increase in percent apoptotic nuclei (Fig 2A) and caspase 3/7 activity (Fig 2B). Treatment of
oleate induce lipoapoptosis only at a concentration of 800 μM. (Fig 2A and 2B). In summary,
we observed that saturated FFAs induce a concentration-dependent increase in placental tro-
phoblast lipoapoptosis.
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Fig 1. FFAs induce trophoblast lipoapoptosis. Cells were treated with palmitate (PA), stearate (SA), oleate (OA) or
vehicle (Veh) for 24 h in JEG-3 (A, B) and JAR cells (C, D). Percent apoptotic nuclei (A and C) and caspase 3/7 activity
PLOS ONE FFAs induces trophoblast lipoapoptosis
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Biochemical evidence for placental trophoblast lipoapoptosis
We assessed the caspase cleavage products of Poly (ADP-ribose) polymerase (PARP) and cas-
pase 3 itself. PARP is a 116 kDa protein with a role in DNA repair, chromatin structure forma-
tion, and differentiation [26]. Treatment of palmitate (600–800 μM) showed a dramatic
increase in the levels of 85 kDa cleaved PARP in JEG-3 and HTR-8 cells after 24 hours (Fig 3A
and 3B). We also observed a similar increase in the levels of cleaved PARP after 24 hours with
stearate treatment in placental trophoblasts (Fig 3A and 3B). Full length caspase 3 is a 35 kDa
(B and D) were significantly elevated in PA- and SA-treated trophoblasts but not in vehicle and OA-treated
trophoblasts (A-D). These data represent the mean ± sem, n = 4 and �P<0.05 compared to vehicle.
https://doi.org/10.1371/journal.pone.0249907.g001
Fig 2. FFAs induce trophoblast lipoapoptosis in human normal immortalized first trimester-derived trophoblast
cells, HTR-8SV/neo (HTR-8). HTR-8 cells were treated with palmitate (PA), stearate (SA), oleate (OA) or vehicle
(Veh) for 24 hr. Percent apoptotic nuclei (A) and caspase 3/7 activity (B) were significantly elevated in PA- and SA-
treated trophoblasts, but not in vehicle and OA-treated trophoblasts. These data represent the mean ± sem, n = 4 and
�P<0.05 compared to vehicle.
https://doi.org/10.1371/journal.pone.0249907.g002
PLOS ONE FFAs induces trophoblast lipoapoptosis
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Fig 3. Biochemical evidence for FFA-induced trophoblast lipoapoptosis. Cells were treated with palmitate (PA),
stearate (SA) (600–800 μM) or Vehicle (Veh) for 24 h. (A) JEG-3 cells treated with 600–800 μM of PA or SA showed
PLOS ONE FFAs induces trophoblast lipoapoptosis
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protein and its activation occurs in two stages. First, caspase 3 is cleaved by upstream caspases
to yield an active 19 kDa cleaved caspase 3. Second, a short pro-domain in the 19 kDa protein
is auto-catalytically processed to generate a mature 17 kDa cleaved caspase 3 [27]. Treatment
of palmitate or stearate, 600–800 μM for 24h to JEG-3 or HTR-8 cells showed a dramatic
increase in the levels of both 19 kDa and 17 kDa active forms of cleaved caspase 3 compared to
vehicle treated cells (Fig 3C and 3D). These results demonstrate further biochemical evidence
for saturated FFA-induced placental trophoblast lipoapoptosis.
LPS aggravates palmitate-induced trophoblast lipoapoptosis
We treated trophoblast cells with 800 μM of PA plus LPS (0.5–1.5 μg/ml). Co-treatment of LPS
(1.0–1.5 μg/ml) aggravates PA-induced trophoblast lipoapoptosis (Fig 4A). However, treat-
ment of LPS alone (0.1–1.5 μg/ml) to placental trophoblast cells did not induce caspase 3/7
activation (Fig 4B). Further, co-treatment of LPS (1.0 μg/mL) with 800 μM of palmitate also
showed enhanced caspase 3/7 activity and percent apoptotic nuclei levels compared to PA
alone in HTR-8 cells (Fig 4C). However, co-treatment of LPS (1.0 μg/mL) with lower concen-
trations (400–600 μM) of palmitate for 24 h did not alter PA-induced trophoblast lipoapopto-
sis (Fig 4C). In summary, LPS exacerbates high levels of palmitate-induced placental
trophoblast lipoapoptosis.
Monounsaturated fatty acids prevents trophoblast lipoapoptosis
Here, we treated JEG-3 cells with 800 μM of palmitate for 24 h and tested the protective role of
palmitoleate or oleate. Treatment of palmitate to placental trophoblasts resulted in a significant
increase in trophoblast lipoapoptosis as evidenced by an increase in percent apoptotic nuclei
and caspase 3/7 activity (Fig 5A and 5B). Co-treatment of palmitoleate (25–100 μM) with
800 μM of palmitate for 24 h significantly protected against palmitate-induced trophoblast
lipoapoptosis (Fig 5A and 5B). Similarly, co-treatment of oleate (50–200 μM) also significantly
prevents palmitate-induced placental trophoblast lipoapoptosis (Fig 5C and 5D). The protec-
tion offered by palmitoleate and oleate support the therapeutic potential of monounsaturated
fatty acids against placental injury and lipotoxicity during maternal obesity.
Discussion
Increased saturated FFAs in pre-pregnancy obesity and maternal obesity could result in pla-
cental lipotoxicity; we observed that saturated FFAs induce placental trophoblast lipoapopto-
sis. The principal findings of this manuscript are: 1) saturated FFAs induce placental
trophoblast apoptosis via caspase 3 and 7 activation, 2) LPS aggravates FFA-induced placental
trophoblast lipotoxicity, in vitro, and 3) co-treatment of monounsaturated fatty acids like pal-
mitoleate and oleate protects against FFA-induced placental trophoblast lipoapoptosis.
Increased placental lipotoxicity associated with decreased FA oxidation were observed in
the placenta of obese mothers compared to non-obese mothers [2, 28]. Palmitate, a predomi-
nant circulating FFA exposure to placental trophoblast has been reported to induce inflamma-
tion, activation of mitogen activated protein kinase and immediate early response
transcription factors like activating transcription factor 3, cJUN and serum response factor
dramatic increase in cleaved PARP levels compared to vehicle treated cells; (B) HTR-8 cells also showed increased
levels of cleaved PARP with 600–800 μM of PA or SA treatment compared to vehicle (Veh) treated cells; (C) JEG-3
cells or (D) HTR-8 cells treated with 600–800 μM of PA or SA for 24 h resulted in increased levels of cleaved caspase 3
(19 kDa and 17 kDa) compared to vehicle (Veh) treated cells. Actin was used as a loading control. Arrows indicates 19
and 17 kDa bands of active forms of cleaved caspase 3.
https://doi.org/10.1371/journal.pone.0249907.g003
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Fig 4. LPS aggravates FFA-induced trophoblast lipoapoptosis. JEG-3 cells were treated with 800 μM of palmitate
(PA) showed increased caspase 3/7 activity. (A) Co-treatment of PA with physiological concentration of LPS (1.0–
1.5 μg/ml) results in aggravation of PA-induced trophoblast lipoapoptosis; (B) JEG-3 cells treated with LPS alone (0.1–
1.5 μg/ml) did not alter caspase 3/7 activity compared to vehicle (Veh) treated cells; (C) Percent apoptotic nuclei and
caspase 3/7 activity were elevated in HTR-8 cells with co-treatment of PA (800 μM) and LPS (1.0 μg/mL) compared to
800 μM of palmitate alone treated cells. These data represent the mean ± sem, n = 4 and �P<0.05 compared to vehicle,
#p<0.05 compared to PA alone treatment.
https://doi.org/10.1371/journal.pone.0249907.g004
PLOS ONE FFAs induces trophoblast lipoapoptosis
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recruitment to early growth response protein 1 (EGR1) promoter [6, 17, 29]. Palmitate-
induced activation of EGR1 expression and inflammation were shown to be dependent of JNK
activation in placental trophoblasts. Further, obese term placentas were also shown to have
increased expression of EGR1 and JNK activation [6, 17]. Palmitate-induced activation of cas-
pases and JNK has been shown to play a critical role in hepatocyte, coronary artery endothelial
cells and pancreatic-β cell lipoapoptosis [30–32]. In the present study, we show evidence for
caspase activation and apoptosis with FFA exposure in placental trophoblast. To further vali-
date the activation of caspase 3 and 7 in placental trophoblasts, we demonstrate the increased
levels of caspase cleaved products suggesting the role of caspases in the mechanism of lipoa-
poptosis. However further investigations are required to elucidate the critical role for JNK acti-
vation in palmitate-induced trophoblast lipoapoptosis.
FFA-induced placental trophoblast lipoapoptosis was also evident in normal human
immortalized first trimester-derived placental trophoblast cells (HTR-8) and term-derived pla-
cental trophoblast cells (JEG-3 and JAR cells). We observed that 400-800 μM of stearate and
600–800 μM of palmitate showed consistently increased lipoapoptosis in all three placental tro-
phoblast cells. However, treatment of 400 μM of palmitate showed increased lipoapoptosis in
JEG-3 cells, were not observed in JAR and HTR-8 cells. Increased sensitivity of palmitate-
induced lipoapoptosis in JEG-3 cells should be compared with primary term-derived tropho-
blasts and requires further investigation. In the present study, we also observed that exposure
of LPS aggravates the FFA-induced trophoblast lipoapoptosis. This data suggests that increased
bacterial endotoxin, LPS and increased FFAs in maternal circulation of obese mothers can
damage placental cells through multiple mechanisms of injury such as LPS-induced inflamma-
tory changes [33] and trophoblast lipoapoptosis. Further studies are required to clearly under-
stand the complex role of LPS-induced inflammation and TLR4 activation with FFA-induced
lipotoxicity in placental trophoblasts.
Co-treatment of monounsaturated fatty acids like palmitoleate or oleate prevents FFA-
induced placental trophoblast lipoapoptosis. Treatment of palmitoleate has been shown to
abolish palmitate-induced endoplasmic reticulum (ER) stress response, lipotoxicity, and acti-
vation of JNK in the hepatocytes [34]. The mechanism of palmitoleate protection against hepa-
tocyte lipoapoptosis is via abrogating the activation mitochondrial pro-apoptotic mediators
like BAX, PUMA and BIM [34]. Palmitoleate is also protective against high-fat diet-induced
decreased mitochondrial oxidative metabolism and activation of proinflammatory cytokines
in the macrophages, respectively [35]. Further, palmitoleate and oleate supplementation results
in increased expression of stearoyl CoA-desaturase 1 (SCD1), an enzyme that can convert satu-
rated FFAs like palmitate into palmitoleate or stearate into oleate and can decrease the lipo-
toxicity of saturated FFAs [34, 36]. In addition, decreased expression of SCD1 enhances
palmitate-induced trophoblast lipotoxicity [23] and biosynthesis of palmitoleate is decreased
in the syncytiotrophoblast obtained from obese mothers compared to normal healthy mothers
[22]. Recently, palmitoleate was also shown to inhibit TNFα, IL-1β and IL-6 proinflammatory
cytokine responses in candida-infection stimulation analysis [37]. In the present study, we
show a dramatic decrease in FFA-induced placental trophoblast lipoapoptosis with the co-
treatment of palmitoleate or oleate. These data suggest that monounsaturated fatty acids like
Fig 5. Monounsaturated fatty acids protect against palmitate (PA)-induced trophoblast lipoapoptosis. JEG-3 cells
were treated with either palmitoleate or oleate alone or in combination with palmitate (PA, 800 μM) for 24 hr. (A-B)
PA-induced an increase in percent apoptotic nuclei levels and caspase 3/7 activity were significantly reduced with the
co-treatment of palmitoleate in JEG-3 cells. (C-D) We also observed a similar protection against PA-induced
trophoblast lipoapoptosis with oleate treatment in JEG-3 cells. These data represent the mean ± sem for n = 3. �
p<0.05, compared to PA (800 μM) alone treated cells, #p<0.05 compared to PA alone treatment.
https://doi.org/10.1371/journal.pone.0249907.g005
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palmitoleate and oleate are anti-inflammatory and anti-apoptotic dietary nutrient molecule.
However further studies are required to test the protective mechanism of monounsaturated
fatty acids against saturated FFA-induced lipotoxicity.
Maternal circulating levels of triglycerides and phospho-lipoprotein lipase activity were
reported to be increased in the placenta of obese mother as compared to lean mother, and
lipid droplet accumulation in the placenta was also reported to be increased in maternal obe-
sity [28]. In addition, circulating concentrations of palmitate was shown to be significantly ele-
vated in maternal pre-pregnancy states and during gestational weeks of 24 and 34 as compared
to normal weight pregnant mothers [38]. Further, increased FFAs levels were also reported in
the pregnant dams of high fat high sucrose fed animals during pregnancy and this study
reported endoplasmic reticulum stress in the brain to the offspring even after weaning, sug-
gesting the lipotoxic role of FFAs to the offspring born to obese dam [39]. In the present study,
we showed that these increased FFAs could cause placental trophoblast lipoapoptosis. In con-
trast, pregnant obese mothers and lean mothers at term were shown to have similar increased
FFA levels due to maternal lipolysis [40]. However, a longitudinal study of circulating FFAs is
required at various stages of gestation in lean and obese mothers.
In conclusion, we showed that saturated FFAs induce placental trophoblast lipoapoptosis.
We also observed that saturated FFAs cause a concentration-dependent increase in placental
trophoblast lipoapoptosis. Further, treatment of saturated FFAs to placental trophoblasts show
increased biochemical markers of apoptosis like cleaved-PARP and cleaved caspase 3. Co-
treatment of palmitate with lipopolysaccharide to placental trophoblasts exacerbates palmi-
tate-induced placental trophoblast lipoapoptosis. Interestingly, co-treatment with monounsat-
urated fatty acids protects against palmitate-induced placental trophoblast lipoapoptosis. The
protection offered by monounsaturated fatty acids support their therapeutic potential for pla-
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